"Vindesine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vinblastine derivative with antineoplastic activity against CANCER. Major side effects are myelosuppression and neurotoxicity. Vindesine is used extensively in chemotherapy protocols (ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS).
| Descriptor ID |
D014751
|
| MeSH Number(s) |
D03.132.436.681.827.830 D03.633.100.473.402.681.827.830
|
| Concept/Terms |
Vindesine- Vindesine
- Vindesin
- Desacetylvinblastine Amide
|
Below are MeSH descriptors whose meaning is more general than "Vindesine".
Below are MeSH descriptors whose meaning is more specific than "Vindesine".
This graph shows the total number of publications written about "Vindesine" by people in this website by year, and whether "Vindesine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vindesine" by people in Profiles.
-
Zelefsky MJ, Kelly WK, Scher HI, Lee H, Smart T, Metz E, Schwartz L, Fuks Z, Leibel SA. Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer. J Clin Oncol. 2000 May; 18(9):1936-41.